Omass Therapeutics Limited
Research and experimental development on biotechnology · Oxford
ActiveUnited KingdomIncorporated 2016Private Limited Company
Financial snapshot
Full financialsPeriod ended 2020-12-31GBPunknown accounts
Net assets
£13.89mLatest reporting periodCash at bank
£10.06mLatest reporting periodTurnover
£0.00Latest reporting periodEmployees
28Latest reporting periodBalance sheet
GBP · unknownInsufficient comparable history
At least two periods with a known, matching scope are required.
Inspect coverageCompany record
- Company number
- 10028228
- Incorporated
- 2016-02-26
- Legal form
- Private Limited Company
- Registered office
- BUILDING 4000, JOHN SMITH DRIVE, OXFORD, OX4 2GX
- SIC codes
- 72110
People & control
View all9Current role holders2Control records without an end date0Outstanding security records
OfficerOther current roles
Audrey Cacalydirector
0Evan Greifdirector
0Carol Anne Schaferdirector
0Scott Billerdirector
0Christopher Ashtondirector
5Nathalie Franchimontdirector
0Oxford Science Enterprises Holdings Ii Limited · Syncona Limited
Activity timeline
- Audrey Cacaly appointed
director
- Evan Greif appointed
director
- Laia Crespo Martin resigned
director
- Diana Bernstein resigned
director
Connected companies
Open networkSvs Research Holdings Limited75–100% shares · 75–100% votes
12406652Capital & security
Public records and extracted accounts. Missing figures are unknown, not zero. Research matches are not necessarily direct awards.